Therapeutic drug monitoring of TNFinhibitors and other therapeutic antibodies.
Develop assays for novel immunotherapy drugs such as pembrolizumab, nivolumab and ipilimumab for monitoring drug levels in patients with lung cancer and malignant melanoma.
Develop assays for measuring rituximab and anti-rituximab for monitoring drug level and anti-drug antibody formation.
Detection of antibodies to transglutaminase in the HUNT4-cohort using an in-house dual label assay in collaborative study “Coeliac disease in HUNT”.
Screening for patient antibodies to HH1, a novel antibody-based drug used in lymphoma clinical trials (Lymrit).
Cavalcanti LM, Thomas WM, Warren DJ, Mathews VJ(2025) Adaptive Feedforward Model Predictive Control for Torque Generation Through Asynchronous Intrafascicular Multi-Electrode Stimulation IEEE Trans Biomed Eng, PP(in press) DOI 10.1109/TBME.2025.3530924, PubMed 40031221
Andersen IL, Lukina P, Dyrli OT, Klaasen RA, Warren DJ, Bolstad N, Mjønes P, Rønne E, Iversen R, Sollid LM, Lundin KEA, Ness-Jensen E(2025) Serological screening for coeliac disease in an adult general population: the HUNT study Gut(in press) DOI 10.1136/gutjnl-2024-333886, PubMed 40011035
Fosså SD, Bjerner LJ, Tandstad T, Brydøy M, Dahl AA, Nome RV, Negaard H, Myklebust TÅ, Haugnes HS(2025) Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge Eur Urol Open Sci, 72, 10-16 DOI 10.1016/j.euros.2024.12.010, PubMed 39897186
